While the blood supply can frequently be taken for granted during routine times, there are actions that can be taken now to support patient access to therapeutic plasma and other blood products during future infectious outbreaks or other disasters that place the blood supply under undue stress.
Beyond COVID-19: Plan Now to Future-Proof Your Therapeutic Plasma.
Our new white paper examines these topics in detail:
As the coronavirus and other recent epidemics have shown, continuity of the blood supply can be significantly affected in the case of disease outbreaks. Potential blood product shortages, and the resulting impact on patients and healthcare systems, can be minimised by implementing new processes now, such as pathogen inactivation, that will safeguard stocks of therapeutic plasma and other blood products in the case of future outbreaks.
The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember: